These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 15453867)

  • 21. Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series.
    Chan WM; Lam DS; Wong TH; Lai TY; Kwok AK; Tam BS; Li KK
    Ophthalmology; 2003 Dec; 110(12):2395-402. PubMed ID: 14644724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to focal laser photocoagulation for radiation retinopathy.
    Bakri SJ; Beer PM
    Ophthalmic Surg Lasers Imaging; 2003; 34(6):475-7. PubMed ID: 14620753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
    Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
    Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.
    Husain D; Kim I; Gauthier D; Lane AM; Tsilimbaris MK; Ezra E; Connolly EJ; Michaud N; Gragoudas ES; O'Neill CA; Beyer JC; Miller JW
    Arch Ophthalmol; 2005 Apr; 123(4):509-16. PubMed ID: 15824225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photodynamic therapy with verteporfin for subfoveal choroidal neovascular membranes in highly myopic eyes after laser in situ keratomileusis.
    Arevalo JF; Ruiz-Moreno JM; Fernandez CF; Mendoza AJ; Ramirez E; Montero JA
    Ophthalmic Surg Lasers Imaging; 2004; 35(1):58-62. PubMed ID: 14750766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study.
    Pece A; Vadalà M; Isola V; Matranga D
    Am J Ophthalmol; 2007 Mar; 143(3):449-54. PubMed ID: 17317390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of verteporfin therapy: a collaboration between pharmaceutical companies, device manufacturers and clinical investigators.
    Huber G; Levy J
    Semin Ophthalmol; 2001 Dec; 16(4):213-7. PubMed ID: 15513443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time course and morphology of vascular effects associated with photodynamic therapy.
    Schmidt-Erfurth U; Niemeyer M; Geitzenauer W; Michels S
    Ophthalmology; 2005 Dec; 112(12):2061-9. PubMed ID: 16325705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.
    Barbazetto I; Burdan A; Bressler NM; Bressler SB; Haynes L; Kapetanios AD; Lukas J; Olsen K; Potter M; Reaves A; Rosenfeld P; Schachat AP; Strong HA; Wenkstern A; ;
    Arch Ophthalmol; 2003 Sep; 121(9):1253-68. PubMed ID: 12963608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
    Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC;
    Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.
    Bressler NM; Bressler SB; Haynes LA; Hao Y; Kaiser PK; Miller JW; Naor J; Potter MJ; Pournaras CJ; Reaves A; Rosenfeld PJ; Schmidt-Erfurth U; Slakter JS; Strong A; Vannier S
    Arch Ophthalmol; 2005 Sep; 123(9):1283-5. PubMed ID: 16157822
    [No Abstract]   [Full Text] [Related]  

  • 32. Verteporfin therapy for myopic choroidal neovascularisation in Indian eyes (one year results).
    Hussain N; Das T; Vashist U; Sumashri K
    Indian J Ophthalmol; 2004 Sep; 52(3):227-31. PubMed ID: 15510463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study.
    Pece A; Isola V; Vadalà M; Matranga D
    Retina; 2006 Sep; 26(7):746-51. PubMed ID: 16963846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Verteporfin photodynamic therapy for the treatment of persistent subfoveal choroidal neovascularization after external beam radiotherapy: one-year results.
    Gupta R; Browning AC; Wu K; Sokal M; Amoaku WM
    Am J Ophthalmol; 2005 Mar; 139(3):561-2. PubMed ID: 15767080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of early retreatment with the standard regimen in verteporfin therapy of neovascular age-related macular degeneration.
    Michels S; Wachtlin J; Gamulescu MA; Heimann H; Prünte C; Inhoffen W; Krebs I; Schmidt-Erfurth U
    Ophthalmology; 2005 Dec; 112(12):2070-5. PubMed ID: 16225928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Verteporfin therapy for CNV secondary to OHS.
    Saperstein DA; Rosenfeld PJ; Bressler NM; Rosa RH; Sternberg P; Aaberg TM; Aaberg TM; Weisberger A
    Ophthalmology; 2006 Dec; 113(12):2371.e1-3. PubMed ID: 17157140
    [No Abstract]   [Full Text] [Related]  

  • 37. [Photodynamic therapy with verteporfin in treating the choroidal neovascularisation secondary to multifocal choroiditis].
    Gebka A; Raczyńska K; Ciechanowski C; Krajka-Lauer J
    Klin Oczna; 2005; 107(1-3):118-20. PubMed ID: 16052820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
    Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
    Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Verteporfin and photosensitivity in diabetic].
    Asensio Sánchez VM; Corral Azor A; García Pascual A
    Arch Soc Esp Oftalmol; 2003 May; 78(5):277-9. PubMed ID: 12789632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study.
    Rosenfeld PJ; Saperstein DA; Bressler NM; Reaves TA; Sickenberg M; Rosa RH; Sternberg P; Aaberg TM; Aaberg TM;
    Ophthalmology; 2004 Sep; 111(9):1725-33. PubMed ID: 15350329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.